Product details
Catalog number #00069
Price for #00069
Size / count 1x 100 µg
Cholera toxin B subunit (CTB) binds GM1 ganglioside. Fluorescent CTB is used to label lipid rafts and as a neuronal retrograde tracer. Biotium's CF® dyes have superior brightness and photostability compared to other dyes. Far-red fluorescent CF®647 dye has excitation/emission at 650/665 nm.
The catalog number for Cholera Toxin B, CF®647 Conjugate, 100 ug is #00069.
Cholera Toxin B, CF®647 Conjugate, 100 ug is available in the following size(s): 1x 100 µg.
Cholera Toxin B, CF®647 Conjugate, 100 ug is currently made to order / not held in immediate stock. Contact us for lead time.
Cholera Toxin B, CF®647 Conjugate, 100 ug is manufactured by Biotium.
Estimated delivery time for Cholera Toxin B, CF®647 Conjugate, 100 ug is approximately 15 business day(s), depending on your location.
The safety data sheet for Cholera Toxin B, CF®647 Conjugate, 100 ug is available here: https://cdn.gentaur.com/products/37/699c39d20d8c9d341e164582/msds/%2300069.pdf.
Cholera toxin B subunit (CTB) binds GM1 ganglioside. Fluorescent CTB is used to label lipid rafts and as a neuronal retrograde tracer. Biotium's CF® dyes have superior brightness and photostability compared to other dyes. Far-red fluorescent CF®647 dye has excitation/emission at 650/665 nm.
Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.
The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.
As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.